NO821496L - Befruktningshindrende gelpreparat. - Google Patents

Befruktningshindrende gelpreparat.

Info

Publication number
NO821496L
NO821496L NO821496A NO821496A NO821496L NO 821496 L NO821496 L NO 821496L NO 821496 A NO821496 A NO 821496A NO 821496 A NO821496 A NO 821496A NO 821496 L NO821496 L NO 821496L
Authority
NO
Norway
Prior art keywords
approx
preparation
preparation according
inhibitor
pharmaceutically acceptable
Prior art date
Application number
NO821496A
Other languages
English (en)
Norwegian (no)
Inventor
Brian H Vickery
Shabbir Anik
Richard E Jones
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO821496L publication Critical patent/NO821496L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/14—Topical contraceptives and spermacides

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fertilizers (AREA)
NO821496A 1981-05-07 1982-05-06 Befruktningshindrende gelpreparat. NO821496L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/261,411 US4368186A (en) 1981-05-07 1981-05-07 Methods and compositions for intravaginal contraception

Publications (1)

Publication Number Publication Date
NO821496L true NO821496L (no) 1982-11-08

Family

ID=22993188

Family Applications (1)

Application Number Title Priority Date Filing Date
NO821496A NO821496L (no) 1981-05-07 1982-05-06 Befruktningshindrende gelpreparat.

Country Status (9)

Country Link
US (1) US4368186A (fr)
EP (1) EP0065385A3 (fr)
JP (1) JPS57192313A (fr)
AU (1) AU8346082A (fr)
DK (1) DK203582A (fr)
FI (1) FI821600L (fr)
IL (1) IL65699A (fr)
NO (1) NO821496L (fr)
ZA (1) ZA823136B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588581A (en) * 1984-11-16 1986-05-13 Basf Corporation Methods and compositions for intravaginal contraception
US4585647A (en) * 1984-11-19 1986-04-29 Basf Corporation Methods and compositions for intravaginal contraception
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
CA1331559C (fr) 1986-04-21 1994-08-23 Jon Joseph Kabara Compositions et methodes pour la conservation antimicrobienne
ATE64854T1 (de) * 1986-05-22 1991-07-15 Atlantic Pharma Prod Zusammensetzung mit hemmender wirkung auf zumindest ein einzelliges lebewesen und/oder virus, herstellungsverfahren und anwendungen dieser zusammensetzung.
FR2598916B1 (fr) * 1986-05-22 1988-09-09 Atlantic Pharma Prod Compose chimique fluore utilise dans une methode de contraception locale et composition contraceptive locale fluoree, notamment spermicide
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
CA1329614C (fr) * 1987-05-02 1994-05-17 Rainer Buerstinghaus Azoles substituees en n
US4904683A (en) * 1987-06-03 1990-02-27 Janssen Pharmaceutica N.V. Emulsifiable concentrates containing azoles
US5545615A (en) * 1987-09-18 1996-08-13 Zymogenetics, Inc. A method of inhibiting fertilization by alpha-1-antitrypsin or antithrombin III
FR2620698B1 (fr) * 1987-09-23 1990-08-10 Atlantic Pharma Prod Fluorure d'ammonium quaternaire et son application dans une substance inhibitrice ou destructrice d'etres vivants unicellulaires
EP0380084A3 (fr) * 1989-01-27 1991-03-13 The Biomembrane Institute Méthode d'inhibition des interactions cellule-cellule et cellule-substrat par blocage des interactions entre hydrates de carbone
US5593683A (en) * 1990-05-01 1997-01-14 Mdv Technologies, Inc. Method of making thermoreversible polyoxyalkylene gels
CA2040460C (fr) * 1990-05-01 1997-06-10 Tacey X. Viegas Distribution de medicaments au moyen de gels thermoreversibles
IT1250748B (it) * 1991-08-02 1995-04-21 Poli Ind Chimica Spa Formulazioni utili per il trattamento della secchezza vaginale
GR1001412B (el) * 1992-10-12 1993-11-30 Poli Ind Chimica Spa Συν?έσεις χρήσιμες δια την ?εραπευτική αγωγή της ξηρότητος του κόλπου.
US6432941B1 (en) * 1998-01-20 2002-08-13 Parker Hughes Institute Vanadium compounds for treating cancer
US6051603A (en) * 1998-01-20 2000-04-18 Wayne Hughes Institute Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
US6245808B1 (en) 1998-11-05 2001-06-12 Parker Hughes Institute Oxy-vanadium (IV) complexes having spermicidal activity
WO2004075854A2 (fr) * 2003-02-26 2004-09-10 Program For Appropriate Technology In Health Compositions microbicides et leur mode d'emploi
US20050037033A1 (en) * 2003-05-23 2005-02-17 Program For Appropriate Technology In Health Microbicidal compositions and methods and use
CA2535951A1 (fr) * 2003-08-14 2005-03-03 The Bio Balance Corporation Souches bacteriennes, compositions les comprenant et leur utilisation dans un traitement probiotique
UA93354C2 (ru) * 2004-07-09 2011-02-10 Гилиад Сайенсиз, Инк. Местный противовирусный препарат
DE602006019733D1 (de) 2005-07-19 2011-03-03 Population Council Inc Verfahren und zusammensetzungen zur notfallbedingten verhütung mithilfe von endothelin-rezeptor-antagonisten
KR101275814B1 (ko) * 2006-06-23 2013-06-18 삼성에스디아이 주식회사 분산제 화합물 및 그의 제조방법
BRPI0904249B1 (pt) * 2009-08-28 2018-03-06 Biolab Sanus Farmacêutica Ltda. Compostos éteres aralquil benzílicos, processo de preparação dos mesmos, uso dos referidos compostos, composição farmacêutica
BR112012013252A2 (en) 2009-12-01 2018-05-29 Seprox Biotech, S.L. topical pharmaceutical composition, preservative, compound, and use thereof
EP2546358A1 (fr) 2011-07-15 2013-01-16 Laboratorios Del. Dr. Esteve, S.A. Procédés et réactifs pour un contrôle efficace de la progression du VIH
EP2606897A1 (fr) 2011-12-22 2013-06-26 Laboratorios Del. Dr. Esteve, S.A. Procédés et compositions pour le traitement des maladies causées par les virus enveloppés
US10016361B2 (en) 2014-10-24 2018-07-10 Francoise Farron PH change in the vagina as a contraceptive

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740421A (en) * 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4100271A (en) * 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4247552A (en) * 1979-01-11 1981-01-27 Syntex (U.S.A.) Inc. Contraceptive compositions and methods employing 1-substituted imidazole derivatives
US4277475A (en) * 1979-01-11 1981-07-07 Syntex (U.S.A.) Inc. Contraceptive methods employing 1-substituted imidazole derivatives

Also Published As

Publication number Publication date
JPS57192313A (en) 1982-11-26
FI821600A7 (fi) 1982-11-08
FI821600L (fi) 1982-11-08
FI821600A0 (fi) 1982-05-06
EP0065385A3 (fr) 1983-06-15
AU8346082A (en) 1983-11-10
EP0065385A2 (fr) 1982-11-24
US4368186A (en) 1983-01-11
IL65699A0 (en) 1982-08-31
IL65699A (en) 1985-01-31
DK203582A (da) 1982-11-08
ZA823136B (en) 1983-12-28

Similar Documents

Publication Publication Date Title
NO821496L (no) Befruktningshindrende gelpreparat.
CN100488517C (zh) 捕获和灭活病原性微生物和精子的组合物及其制药用途
US5545401A (en) Antiviral, spermicidal vaginal gel and foam containing low molecular weight povidone-iodine
US4252787A (en) Anti-fertility composition and method
US8193248B2 (en) Contraceptive composition
AU2001243431A1 (en) Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
US20040180965A1 (en) Gel composition and method for treatment of vaginal infections
KR20050025166A (ko) 가온성 및 무자극성 윤활제 항진균성 겔 조성물
US20140349936A1 (en) Compositions and methods for treating precocious puberty
WO2020011845A1 (fr) Compositions ophtalmiques contenant un prostamide libérant de l'oxyde nitrique
JPS5931714A (ja) 避妊組成物
US4585647A (en) Methods and compositions for intravaginal contraception
Benagiano et al. Contraceptive devices: intravaginal and intrauterine delivery systems
WO2000053183A1 (fr) Medicament contre la dysmenorrhee et le syndrome premenstruel
US20190262361A1 (en) Progesterone Receptor Modulators for Use in the Therapy of Uterine Fibroids
Homm et al. ORF 13904, a new long-acting vaginal contraceptive
US20030091642A1 (en) Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof
ZANEVELD et al. Properties of a New, Long‐Lasting Vaginal Delivery System (LASRS) for Contraceptive and Antimicrobial Agents
US20240115490A1 (en) Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof
Sahu et al. Innovation and Challenges in Male Contraception.
UA135665U (uk) Фармацевтична композиція для лікування проктологічних захворювань
US20110082128A1 (en) In-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts
JP2026511100A (ja) 保護用の生体応答性ポリマーシール
CN101116657B (zh) 外用避孕乳胶剂及其制备方法
WO2001080861A1 (fr) Sterilite ou augmentation de la fecondite